Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder

Acamprosate is an anti-craving drug used in alcohol use disorder (AUD) pharmacotherapy. However, only a subset of patients achieves optimal treatment outcomes. The identification of predictive biomarkers of acamprosate treatment response in patients with AUD would be a substantial advance in addicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Ming-Fen, Zhang, Cheng, Moon, Irene, Coombes, Brandon J., Biernacka, Joanna, Skime, Michelle, Choi, Doo-Sup, Croarkin, Paul E., Frye, Mark A., Ngo, Quyen, Skillon, Cedric, Oesterle, Tyler S., Karpyak, Victor M., Li, Hu, Weinshilboum, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475292/
https://www.ncbi.nlm.nih.gov/pubmed/36120372
http://dx.doi.org/10.3389/fphar.2022.986238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475292/
https://www.ncbi.nlm.nih.gov/pubmed/36120372
http://dx.doi.org/10.3389/fphar.2022.986238

Ejemplares similares